In this study, we profiled CNAs in the tumor tissue from pediatric cancer, including embryonic tumors, followed by further evaluation of CNAs in 1q, MYCN and 17p in the circulating cell-free DNA (cfDNA) from plasma samples for long-term disease monitoring through liquid biopsy. This evidence concerns the gene MYCN and cancer.